Literature DB >> 3431913

Renal cell carcinoma. II. Histological indicators of prognosis.

B Delahunt1, J N Nacey.   

Abstract

Tissue obtained from 102 renal tumours presenting over a 21-year period was reviewed in an attempt to identify histological features of prognostic importance. Statistical analysis showed the grade of nuclear pleomorphism to have a significant bearing on survival. Application of the proportional hazard model, and using the grade of nuclear pleomorphism as a baseline index, showed mitotic rate, pseudocapsule thickness and the presence of sarcomatoid tumour cells to have an independent association with survival. The presence of tumour cells with granular cytoplasm was correlated with outcome; however, this parameter was not independent of grade of nuclear pleomorphism. Tumour pattern, intensity of lymphocytic infiltrate, degree of fibrosis, necrosis and hemorrhage, and amount of haemosiderin and dystrophic calcification were found to have no association with survival.

Entities:  

Mesh:

Year:  1987        PMID: 3431913     DOI: 10.3109/00313028709066560

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  9 in total

1.  Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols.

Authors:  Miguel Villalobos-Gollás; Bernardo Aguilar-Davidov; Carolina Culebro-García; Martha O Gómez-Alvarado; Priscila Rojas-Garcia; Raúl Ibarra-Fombona; Norma Uribe-Uribe; Guillermo Feria-Bernal; Ricardo Castillejos-Molina; Mariano Sotomayor; Fernando Gabilondo; Francisco Rodríguez-Covarrubias
Journal:  Int Urol Nephrol       Date:  2012-05-22       Impact factor: 2.370

2.  [The WHO/ISUP grading system for renal carcinoma].

Authors:  H Moch
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

3.  Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors.

Authors:  G Chemeris; A Loktinov; A Rempel; M Schwarz; P Bannasch
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Multilayer control of cardiac electrophysiology by microRNAs.

Authors:  Dandan Yang; Isabelle Deschênes; Ji-Dong Fu
Journal:  J Mol Cell Cardiol       Date:  2022-03-03       Impact factor: 5.763

Review 5.  [Chromophobe renal cell carcinoma-diagnosis and prognosis].

Authors:  F Erlmeier
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

6.  Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?

Authors:  Tahir Qayyum; Peter McArdle; Clare Orange; Morag Seywright; Paul Horgan; Grenville Oades; Michael Aitchison; Joanne Edwards
Journal:  Springerplus       Date:  2013-08-10

Review 7.  Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.

Authors:  Ashutosh Chauhan; Deepak Kumar Semwal; Satyendra Prasad Mishra; Sandeep Goyal; Rajendra Marathe; Ruchi Badoni Semwal
Journal:  Med Sci (Basel)       Date:  2016-10-17

8.  Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma.

Authors:  Jae Won Joung; Hoon Kyu Oh; Sun Jae Lee; Young Ah Kim; Hyun Jin Jung
Journal:  J Pathol Transl Med       Date:  2018-08-19

9.  Iron accumulation typifies renal cell carcinoma tumorigenesis but abates with pathological progression, sarcomatoid dedifferentiation, and metastasis.

Authors:  Christopher J Greene; Kristopher Attwood; Nitika J Sharma; Benjamin Balderman; Rongia Deng; Jason B Muhitch; Gary J Smith; Kenneth W Gross; Bo Xu; Eric C Kauffman
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.